secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001493152-24-005398
Event type: other_material
Sentiment:  positive
Materiality: 0.45
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics announces three US patents for fibroblast technology
-------------------------------------------------------------------

- Patent 11,717,596 (Sevrain): Methods for cartilage repair using in vivo bioreactor.
- Patent 11,732,239 (O'Heeron): Treatment of disc degenerative disease with fibroblast conditioned media.
- Patent 11,819,555 (O'Heeron): Gene therapy for regeneration of chondrocytes or cartilage-type cells.
- Company now holds 150+ patents issued and pending, reinforcing its IP portfolio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224005398/0001493152-24-005398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000149315224005398/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-005398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer